Effect of Bioptron on Scar Formation After Cesarean Section
NCT ID: NCT06796933
Last Updated: 2025-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-01-27
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative in Cesarean Section, the Women Suffering from Pain Due to Wound "incisional Pain", High Level Laser One of Most Effective Methods That Promoting Healing and Decrease Pain so It Will Effective If Use in Decreasing Pain of Cesarian Section
NCT06793293
Photo-biomodulation Therapy for Pain Relief After Caesarean Section
NCT05738239
Efficacy of Diathermy on Healing Power of Cesarean Section Scar
NCT03988972
Effect of Onion Extract Nanoparticle Gel Phonophoresis on Postsurgical Scar of Cesarean Section.
NCT06658444
EFFECT OF SCAR RELEASE TECHNIQUES ON CHRONIC SCAR PAIN AND MOBILITY POST CESAREAN SECTION
NCT05391685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A scar is a natural outcome of the healing process following a wound. Complaints associated with scars can lead to both physical discomfort and psychological challenges. Enhanced healing of CS scars could lead to better postoperative outcomes, reducing complications such as infection, pain, and restricted mobility. These aspects of recovery are often neglected, as noted by.
This study will be the first to specifically examine the effects of Bioptron light therapy on CS scar formation. While previous research has shown the benefits of this therapy on scars from various operations, none have focused on CS scars. By investigating this innovative, non-invasive treatment approach, the study aims to fill a critical gap in existing research and offer valuable insights into managing and improving postoperative recovery for CS patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Silicone-based products group
The participants will be treated with cosmetic creams such as Silicone-based products, (silicone gels for 1 month).
Silicon based products (silicon gel)
The participants will be treated with cosmetic creams such as Silicone-based products (silicone gels twice a day) for one month.
Bioptron and Silicone-based products group
The participants will be treated by polarized light therapy (Bioptron) for 15 minutes, 3 sessions per week, in addition to the cosmetic creams (Silicone-based products; silicone gels) for one month.
Silicon based products (silicon gel)
The participants will be treated with cosmetic creams such as Silicone-based products (silicone gels twice a day) for one month.
Bioptron (polarized light therapy)
The participants will be treated by polarized light therapy (Bioptron) for 15 minutes, 3 sessions per week, for one month.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Silicon based products (silicon gel)
The participants will be treated with cosmetic creams such as Silicone-based products (silicone gels twice a day) for one month.
Bioptron (polarized light therapy)
The participants will be treated by polarized light therapy (Bioptron) for 15 minutes, 3 sessions per week, for one month.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Their body mass index (BMI) will not exceed 30 kg/m2.
* They will be primipara and having abdominal scar after CS.
* The scar age will be extended from 6 weeks to 6 months.
* All women will be medically stable when attending the study.
Exclusion Criteria
* Women having diabetes mellitus.
* Women taking immunosuppressant drugs.
20 Years
30 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ghadeer Abdelazzim Mostafa
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamer Assar, Professor
Role: STUDY_DIRECTOR
Benha University
Mohamed Awad, Professor
Role: STUDY_CHAIR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ghadeer Abdelazim Mostafa
Banhā, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/005315
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.